Accelerate Diagnostics Annual Revenue, Competitors, Number of Employees and Funding

Accelerate Diagnostics, Inc. (Nasdaq:AXDX), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. The company's revolutionary ID/AST platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. In addition to the ID/AST development pipeline, the company also owns and licenses its proprietary OptiChem surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.